The AVRW Sera Labs product line has never been more appealing and effective. Everyone can see it here and place orders too: https://seralabshealth.com/
AVRW is due to report Q3 numbers this month by November 15th. Management is very reliable about keeping all its filings up to date so the stock remains in good standing for its OTC listing. We will likely see the upcoming filing on time and hopefully some fresh news on progress and the latest developments. Lots of potential for pps rise here from current base trading levels.